More recent clinical trial results show AstraZeneca's COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
